Overview

Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Diclofenac sodium 0.1% will be applied to sunburned skin when the intensity of pain reaches a certain level in order to evaluate the efficacy and safety of the treatment on this induced pain.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Diclofenac